Introduction
============

In the process of orthodontics treatment, mechanical force is loaded on the tooth, resulting in the production of inflammatory mediators in periodontal tissues, and the surrounding alveolar bone is remodeled. According to the pressure-tension theory ([@b1-mmr-16-06-9415]), bone resorption occurs on the side of root under pressure, while bone formation occurs on the other side of the root under tension. The bone remodeling in the dental and periodontal tissues enables the tooth to move in the alveolar bone ([@b2-mmr-16-06-9415],[@b3-mmr-16-06-9415]). A previous study demonstrated alternations of the alveolar bone density due to active bone remodeling during orthodontic treatment, the reduction of alveolar bone density results from less bone mineral content as a result of resorption of pre-existing bone tissue and formation of new bone tissue during the process of bone remodeling ([@b4-mmr-16-06-9415]). Therefore, it is likely that bone mineral density (BMD) reflects progress of bone remodeling during orthodontic treatment. Additionally, some cell factors and proteins including tumor necrosis factor ligand superfamily member-11 (RANKL), osteoprotegerin (OPG), lubricin and tumor necrosis factor-related apoptosis-inducing ligand were also proved to influence the bone remodeling in orthodontic tooth movement (OTM) ([@b5-mmr-16-06-9415]--[@b7-mmr-16-06-9415]).

Hydrogen sulfide (H~2~S) can be produced by at least three enzymes: Cystathionine β-synthetase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase in mammals ([@b8-mmr-16-06-9415],[@b9-mmr-16-06-9415]). As a gasotransmitter, H~2~S serves a vital role in various physiological and pathophysiological processes, including vasodilation, neurotransmission, inflammation, anti-inflammation and hypoxia sensing ([@b10-mmr-16-06-9415]--[@b14-mmr-16-06-9415]). In rat periodontal tissues, H~2~S increases the osteoclast activity and upregulates RANKL expression levels ([@b15-mmr-16-06-9415],[@b16-mmr-16-06-9415]). It was reported that human periodontal ligament stem cells (PDLSCs), expressed both CBS and CSE and produced H~2~S, which maintained the osteogenic capacity of PDLSCs ([@b17-mmr-16-06-9415]). Our previous study indicated that human PDLSCs produced H~2~S via CSE, and the mechanical stimuli increased the mRNA expression levels of CSE. Another study suggested that mechanical stimuli promoted the production of H~2~S in human PDLSCs ([@b18-mmr-16-06-9415]). In has also been demonstrated that H~2~S could promote osteogenic differentiation of human PDLSCs by activating the p38-mitogen-activated protein kinase and the extracellular signal-regulated kinase signaling pathways ([@b19-mmr-16-06-9415]).

However, the effect of H~2~S on alveolar bone remodeling has not been extensively investigated, as most studies are based on *in vitro* investigation without *in vivo* evidence. The aim of this study was to explore the effects of H~2~S on alveolar bone formation and resorption in an OTM mouse model. Results of this study may provide an understanding on H~2~S mechanisms of action on orthodontic tooth movement and a potential approach to accelerate orthodontic treatment.

Materials and methods
=====================

### Animals

A total of 60 8-week old male C57BL6/J mice were used in this study in accordance with a protocol approved by the Animal Use and Care Committee of Tongji University (Shanghai, China). This study was granted ethical approval by Medical Ethics Committee of Tongji University, Shanghai, China. Mice were housed under specific pathogen-free conditions with a controlled temperature (22±1°C), humidity (40--60%) and a 12-h light/dark cycle. The animals were given soft diet and water, *ad libitum*. The general condition and weight of each animal in this study were monitored during all experiments. In the present study, mice were divided into four groups, including a control (n=15), a sodium hydrosulfide (NaHS; n=15), a DL-propargylglycine (PAG; n=15) and a combination group (PAG+NaHS; n=15). Both NaHS (a H~2~S donor, Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and PAG (a CSE inhibitor, Sigma-Aldrich; Merck KGaA) were administered intraperitoneally at a dose of 10 mg/kg/day for 14 days, and a micro-computed tomography (micro-CT) scan was performed on day 14. Following the sacrifice of mice with an overdose of anesthetic (10% chloralic hydras, 400 mg/kg, Sigma-Aldrich; Merck KGaA), tissues were collected for further histological, immunohistochemical and molecular biology analyses. Briefly, tissues were fixed in 4% paraformaldehyde at 4°C for 24 h, followed by incubation with 10% ethylenediaminetetraacetic Acid (pH 7.4) for decalcification (4°C for 4 weeks). Sections (5 µm thick) were cut by a microtome (Leica RM2235, Leica Microsystems Ltd., Wetzlar, Germany) in a mesiodistal direction parallel to the long axis of mesial root of the first molar. Sections that included mesial roots and the alveolar bone of the first molar were selected for titrate-resistant acid phosphatase (TRAP) and immunohistochemical staining.

### Establishment of the OTM model

An OTM mouse model was set up as described in a previous study ([@b20-mmr-16-06-9415]). Orthodontic force was generated by a nickel-titanium coiled spring (0.2 mm in thickness, 1 mm in diameter and 1 mm in length, Smart Technology Co, Ltd., Beijing, China) bonded between the maxillary right first molar and the incisors with flowable restorative resin (3M ESPE, St. Paul, MN, USA), producing \~35 g force ([@b21-mmr-16-06-9415]) ([Fig. 1](#f1-mmr-16-06-9415){ref-type="fig"}). A dynamometer (YDM Corporation, Tokyo, Japan) was used to measure the force accurately. The distance between the first and the second molar in mice was identified as OTM.

### Micro-CT scanning

Microarchitecture of the maxillary was scanned and the distance between the maxillary first and the second molar was measured using micro-CT (SCANCO Medical AG, Bruttisellen, Switzerland). The BMD of alveolar bone in the root furcation area was analyzed quantitatively by a self-contained 3D analysis software of micro-CT (SCANCO Medical AG, Bruttisellen, Switzerland), by assessing the bone volume over total volume (BV/TV).

### TRAP immunohistochemistry

TRAP staining (37°C, 1 h) was performed to identify and quantify osteoclasts using a TRAP ELISA kit (cat. no. 387A, Sigma-Aldrich; Merck KGaA) according to the manufacturer\'s protocol. The osteoclasts of the alveolar bone located between the first and second molar were counted under a confocal microscope (NIKON ECLIPSE 80i, Nikon Corporation, Tokyo, Japan).

### RNA extraction and reverse transcription polymerase chain reaction (RT-qPCR)

Total RNA was extracted from the alveolar bone surrounding the upper region of the first molar using TRIzol reagent (Sigma-Aldrich; Merck KGaA). A RT-qPCR Kit (Takara Bio, Inc., Otsu, Japan) was used to reverse transcribe the RNA to complementary (c)DNA, according to the manufacturer\'s protocol, the conditions of reactions were: 30°C for 10 min, 42°C for 30 min, 99°C for 5 min and 4°C for 5 min. Relative mRNA levels of alkaline phosphatase *(ALP)*, osteocalcin *(OCN)*, *OPG* and *RANKL* were determined using a SYBR Green PCR Master mix and an ABI 7500 Real-Time PCR Detection System (Roche Diagnostics, Basel, Switzerland). Primer sequences are listed in [Table I](#tI-mmr-16-06-9415){ref-type="table"}. The conditions of reactions were: Initial denaturation at 94°C for 3 min and followed by 35 cycles of denaturation at 95°C for 10 sec, and annealing at 57°C for 30 sec. Reactions were run in triplicate and mean-averaged the results. Relative fold changes were calculated using the method of 2^−ΔΔCq^ ([@b22-mmr-16-06-9415]). GAPDH was used as the housekeeping gene.

### Immunohistochemistry

Following routine deparaffinage with 100% xylene for 20 min at room temperature, and hydration with alcohol gradient, 3% H~2~O~2~ was used to inactivate endogenous enzymes for 30 min at room temperature. Antigen repair was performed with Trypsin (Sigma-Aldrich; Merck KGaA) for 20 min at room temperature. Sections were incubated with primary antibodies (ALP, cat. no. SAB3700030; OCN, cat. no. SAB1306277; OPG, cat. no. SAB4502041, and RANKL, cat. no. SAB4503430; all 1:200, Sigma-Aldrich; Merck KGaA) at 37°C for 1 h. Sections were also incubated with second antibody (cat. no. B3640, 1:200, Sigma-Aldrich; Merck KGaA) at 37°C for 1 h. Positive staining was visualized with the DAB (D8001, Sigma-Aldrich; Merck KGaA) and counterstained with hematoxylin.

### Statistical analysis

Data are expressed as the mean ± standard deviation. One-way analysis of variance was performed followed by Tukey\'s test using the SPSS software (version 20.0, IBM Corp., Armonk, NY, USA). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Effect of H~2~S on OTM

When compared with the control animals ([Fig. 2A](#f2-mmr-16-06-9415){ref-type="fig"}; 127±15 µm) NaHS resulted in a significant increase in the OTM ([Fig. 2B](#f2-mmr-16-06-9415){ref-type="fig"}; 341±14 µm, P\<0.01). There was a significant decrease in the OTM in the PAG-treated group ([Fig. 2C](#f2-mmr-16-06-9415){ref-type="fig"}; 58±10 µm, P\<0.01) compared with the control. Notably, NaHS rescued the decreased OTM induced by PAG ([Fig. 2D](#f2-mmr-16-06-9415){ref-type="fig"}; 235±6 µm, P\<0.01 and [Fig. 2E](#f2-mmr-16-06-9415){ref-type="fig"}; 58±10 µm, P\<0.01).

### Effect of H~2~S on BMD

Compared with the control group (56±8%), there was a significant decrease in the BMD measured in the root furcation area in the NaSH group (33±7%, P\<0.05). The PAG group (72±15%, P\<0.05) demonstrated significantly higher BMD than the control group (56±8%). Finally, NaHS (46±6%, P\<0.05) down-regulated the increased BMD-induced by PAG (72±15%; [Fig. 3](#f3-mmr-16-06-9415){ref-type="fig"}).

### Effect of H~2~S on osteoclast numbers

To explore the effect of H~2~S on bone resorption, the osteoclasts in the alveolar bone between the first and the second molar were identified and quantified with TRAP staining ([Fig. 4A-D](#f4-mmr-16-06-9415){ref-type="fig"}). Treatment of NaHS ([Fig. 3A and B](#f3-mmr-16-06-9415){ref-type="fig"}; 36±4, P\<0.05) increased the number of osteoclasts whereas PAG (7±1, P\<0.05) decreased their number, compared with the control group ([Fig. 4C and E](#f4-mmr-16-06-9415){ref-type="fig"}; 10±2). In addition, the PAG+NaHS group (21±2, P\<0.01) indicated a significant increase in the number of osteoclasts compared with the PAG group (7±1; [Fig. 4D and E](#f4-mmr-16-06-9415){ref-type="fig"}).

### Effect of H~2~S on mRNA and protein expression levels of OCN, ALP, RANKL, OPG and RANKL/OPG

To further understand the effect of H~2~S on bone resorption and bone formation, mRNA and protein expression levels of OCN, ALP, RANKL and OPG in the alveolar bone were investigated. Results demonstrated that both the treatment of NaHS alone and NaHS combined with PAG significantly up-regulated the mRNA expression levels of OCN, ALP and RANKL, whereas it down-regulated the mRNA expression levels of OPG. However, PAG administration decreased significantly the mRNA expression levels of OCN, ALP, and RANKL and increased the mRNA expression levels of OPG ([Fig. 5A-D](#f5-mmr-16-06-9415){ref-type="fig"}). The mRNA expression ratio of RANKL/OPG was up-regulated by NaHS and down-regulated by PAG ([Fig. 5E](#f5-mmr-16-06-9415){ref-type="fig"}). Similarly, both the treatment of NaHS alone and NaHS combined with PAG significantly up-regulated the protein expression levels of OCN, ALP and RANKL whereas down-regulated OPG protein expression levels. Additionally, PAG administration decreased significantly the protein expression levels of OCN, ALP and RANKL, and increased OPG protein expression levels ([Fig. 6](#f6-mmr-16-06-9415){ref-type="fig"}).

Discussion
==========

Orthodontic treatment usually lasts 24 to 30 months ([@b23-mmr-16-06-9415]). The long treatment duration could increase the risk of caries development, root resorption and periodontal problems ([@b24-mmr-16-06-9415]--[@b26-mmr-16-06-9415]). Accelerating OTM and shortening the time of treatment has become a crucial research area. OTM occurs in the presence of a mechanical stimulus sequenced by remodeling of the alveolar bone and periodontal ligament ([@b1-mmr-16-06-9415]). It was reported that cyclical forces of 60Hz could increase the rate of OTM ([@b27-mmr-16-06-9415]). Periodontally accelerated osteogenic orthodontics has also been proved to be a safe technique to accelerate tooth movement by reducing the treatment time ([@b28-mmr-16-06-9415]). It is well known that the OTM can be controlled by the size of the applied force and the biological responses from the periodontal ligament, such as the release of inflammatory mediators including cytokines, growth factors, neurotransmitters and arachidonic acid metabolites ([@b2-mmr-16-06-9415]). One of the cytokines, RANKL is considered to be involved in the acceleration of tooth movement by binding to the RANK on osteoclasts stimulating osteoclastogenesis ([@b29-mmr-16-06-9415]). OPG, a circulating glycoprotein, binds to RANKL and inhibits osteoclast activities by competitively inhibiting the RANKL-RANK interaction ([@b30-mmr-16-06-9415]). The balance between RANKL and OPG levels determines osteoclast activation, skeletal calcium release and bone remodeling ([@b31-mmr-16-06-9415]).

H~2~S, a gasotransmitter, serves many physiological and pathophysiological roles in maintaining the normal activity of various organs in the neuronal, cardiovascular, gastrointestinal and respiratory systems ([@b10-mmr-16-06-9415],[@b11-mmr-16-06-9415],[@b32-mmr-16-06-9415],[@b33-mmr-16-06-9415]). A previous study indicated that bone marrow mesenchymal stem cells could produce H~2~S, regulating osteogenic differentiation and cell self-renewal, and that H~2~S deficiency could lead to defects in their differentiation ([@b34-mmr-16-06-9415]). Our previous *in vitro* study also demonstrated that H~2~S could promote osteogenic differentiation by up-regulating the expression ratio of OPG/RANKL expression in human PDLSCs ([@b18-mmr-16-06-9415]). It was also demonstrated that H~2~S significantly increased the expression of ALP, OCN, runt-related transcription factor 2 and collagen 1 in the human PDLSCs with tension force stimulation, and promoted osteogenic differentiation of human PDLSCs by activating the p38-MAPK and ERK signaling pathways ([@b19-mmr-16-06-9415],[@b35-mmr-16-06-9415]). In the present study, exogenous H~2~S could up-regulate the expression of ALP and OCN, the ratio of RANKL/OPG and the number of osteoclasts in the alveolar bone. ALP has been commonly studied as an early marker of osteogenic differentiation in tension force experiments and OCN is a key transcription factor in the modulation of osteogenic differentiation and bone formation ([@b19-mmr-16-06-9415]). The results of the present study revealed that H~2~S could up-regulate the process of osteogenesis, osteoclastic activities and bone remodeling. These findings are consistent with our previous study, where mechanical stimulation and H~2~S could enhance the osteogenic differentiation ([@b18-mmr-16-06-9415],[@b19-mmr-16-06-9415],[@b35-mmr-16-06-9415]). These results were also in accordance with some studies illustrating that H~2~S could enhance RANKL-induced osteoclast differentiation *in vitro* and induce osteoclast differentiation *in vivo* ([@b17-mmr-16-06-9415],[@b36-mmr-16-06-9415]).

It is generally known that remodeling and modeling of alveolar bone is considered as the most important aspect in orthodontic tooth movement ([@b37-mmr-16-06-9415],[@b38-mmr-16-06-9415]). In the present study, non-invasive micro-CT was used to monitor the migration of tooth and the internal conditions of the alveolar bone, such as bone density, during orthodontic and H~2~S treatment. Data of the present study indicated that systemic administration of NaHS accelerated the OTM and reduced the alveolar bone density, providing evidence supporting that H~2~S could promote osteogenesis and osteoclastogenesis differentiation, and might facilitate the tooth movement during orthodontic treatment. In addition, it was observed that PAG decreased the OTM in the mouse model. This change might be associated with a reduction of endogenous H~2~S.

It is worth noting that the present study was based on an OTM mouse model, and is different from clinical work. The mechanism of how H~2~S regulates OTM is still unclear. However, the present study may provide a novel understanding on how to accelerate the tooth movement and shorten the treatment time.

In conclusion, the present study provided an *in vivo* evidence that H~2~S increased the rate of tooth movement by promoting osteogenesis and osteoclastogenesis differentiation in alveolar bone. These findings could encourage further studies looking for a potential therapeutic value of H~2~S for accelerating the orthodontic treatment.
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![Representative image of the orthodontic appliance in an OTM mouse model.](MMR-16-06-9415-g00){#f1-mmr-16-06-9415}

![Micro-computed tomography images of interdental distance between first and second molar teeth of the (A) control, (B) NaHS, (C) PAG and (D) PAG+NaHS groups, and (E) quantification of the changes in the molar tooth movement. Data are presented as the mean ± standard deviation. \*\*P\<0.01. OTM, orthodontic tooth movement; NaHS, sodium hydrosulfide; PAG, propargylglycine.](MMR-16-06-9415-g01){#f2-mmr-16-06-9415}

![NaHS decreases BMD of alveolar bone in root furcation area. (A) Representative image depicting the region of root furcation and (B) quantification of BMD of alveolar bone in all groups. Data are presented as the mean ± standard deviation. \*P\<0.05. OTM, orthodontic tooth movement; NaHS, sodium hydrosulfide; PAG, propargylglycine; BMD, bone mass density; BV/TV, bone volume over total volume.](MMR-16-06-9415-g02){#f3-mmr-16-06-9415}

![Tartrate-resistant acid phosphatase^+^ osteoclasts in alveolar bone between first and second molar in the (A) control, (B) NaHS, (C) PAG and (D) PAG+NaHS groups. Magnification, ×100. (E) Quantification of the number of osteoclasts among the groups following each treatment. Arrows indicate the osteoclasts. Data are presented as the mean ± standard deviation. \*P\<0.05; \*\*P\<0.01. OTM, orthodontic tooth movement; NaHS, sodium hydrosulfide; PAG, propargylglycine.](MMR-16-06-9415-g03){#f4-mmr-16-06-9415}

![mRNA expression levels of (A) OCN, (B) ALP, (C) RANKL, (D) OPG and (E) ratio of RANKL/OPG in the alveolar bone surrounding the upper first molar region. Data are presented as the mean ± standard deviation. \*P\<0.05; \*\*P\<0.01. OTM, orthodontic tooth movement; NaHS, sodium hydrosulfide; PAG, propargylglycine; ALP, alkaline phosphatase; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, tumor necrosis factor ligand superfamily member-11.](MMR-16-06-9415-g04){#f5-mmr-16-06-9415}

![Protein expression levels of ALP in the (A) control, (B) NaHS, (C) PAG and (D) PAG+NaHS groups; of OCN in the (E) control, (F) NaHS, (G) PAG and (H) PAG+NaHS groups; of RANKL in the (I) control, (J) NaHS, (K) PAG and (L) PAG+NaHS groups; of OPG in the (M) control, (N) NaHS, (O) PAG and (P) PAG+NaHS groups. Original magnification, ×100. Arrows indicate positive staining. OTM, orthodontic tooth movement; NaHS, sodium hydrosulfide; PAG, propargylglycine; ALP, alkaline phosphatase; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, tumor necrosis factor ligand superfamily member-11.](MMR-16-06-9415-g05){#f6-mmr-16-06-9415}

###### 

Primer sequences of *ALP, OCS, OPG, RNKL* and *GAPDH*.

  Gene    Primer Sequence (5′-3′)      Length (bp)
  ------- ---------------------------- -------------
  ALP     F: ACACTCGGCCGATCGGGACT      20
          R: CCGCCACCCATGATCACGTCG     21
  OCN     F: TAGTGAACAGACTCCGGCGCTA    22
          R: TGTAGGCGGTCTTCAAGCCAT     21
  OPG     F: GTGGAATAGATGTCACCCTGTGT   23
          R: TTTGGTCCCAGGCAAACTGT      20
  RANKL   F: CAGAAGATGGCACTCACTGCA     21
          R: CACCATCGCTTTCTCTGCTCT     21
  GAPDH   F:AGCAGTCCCGTACACTGGCAAAC    23
          R:TCTGTGGTGATGTAAATGTCCTCT   24

F, forward; R, reverse; ALP, alkaline phosphatase; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, tumor necrosis factor ligand superfamily member-11.
